These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34165356)

  • 1. Vignettes to Illustrate the Value of Tumor Biobanks in Cancer Research in Canada.
    Tarling T; Matzke LAM; Rush A; Gali B; Byrne JA; Watson PH
    Biopreserv Biobank; 2022 Feb; 20(1):75-83. PubMed ID: 34165356
    [No Abstract]   [Full Text] [Related]  

  • 2. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
    Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
    Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia.
    Anisimov SV; Meshkov AN; Glotov AS; Borisova AL; Balanovsky OP; Belyaev VE; Granstrem OK; Grivtsova LY; Efimenko AY; Pokrovskaya MS; Semenenko TA; Sukhorukov VS; Kaprin AD; Drapkina OM
    Biopreserv Biobank; 2021 Feb; 19(1):73-82. PubMed ID: 33058731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Approach to Evaluate the Costs and Outputs of Academic Biobanks.
    Rush A; ; Catchpoole DR; Watson PH; Byrne JA
    Biopreserv Biobank; 2024 Oct; 22(5):463-474. PubMed ID: 38666406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.
    Somiari SB; Somiari RI
    Adv Exp Med Biol; 2015; 864():11-27. PubMed ID: 26420610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of biobanks on research outcomes in rare diseases: a systematic review.
    Garcia M; Downs J; Russell A; Wang W
    Orphanet J Rare Dis; 2018 Nov; 13(1):202. PubMed ID: 30419920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biospecimen Complexity and the Evolution of Biobanks.
    Hartman V; Matzke L; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):264-270. PubMed ID: 31188632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EuPA Biobank Initiative: Meeting the future challenges of biobanking in proteomics & systems medicine.
    Wheelock ÅM; Paulson L; Litton JE;
    J Proteomics; 2015 Sep; 127(Pt B):414-6. PubMed ID: 26216594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Indicators in the Context of Biobanking.
    Slušná ĽK; Balog M
    Biopreserv Biobank; 2023 Aug; 21(4):318-326. PubMed ID: 36099204
    [No Abstract]   [Full Text] [Related]  

  • 10. A strategic plan for the second phase (2013-2015) of the Korea biobank project.
    Park O; Cho SY; Shin SY; Park JS; Kim JW; Han BG
    Osong Public Health Res Perspect; 2013 Apr; 4(2):107-16. PubMed ID: 24159540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biobanking and the further development of precision medicine].
    Dahl E
    Pathologe; 2018 Jul; 39(4):308-312. PubMed ID: 29876651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.
    Hofman V; Ilie M; Long E; Washetine K; Chabannon C; Figarella-Branger D; Clément B; Mabile L; Cambon-Thomsen A; Boucher P; Dagher G; Hewitt R; Parodi B; Hofman P
    Biopreserv Biobank; 2013 Aug; 11(4):235-44. PubMed ID: 24845591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biospecimens and Biobanking in Global Health.
    Mendy M; Lawlor RT; van Kappel AL; Riegman PHJ; Betsou F; Cohen OD; Henderson MK
    Clin Lab Med; 2018 Mar; 38(1):183-207. PubMed ID: 29412882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biospecimen Complexity-the Next Challenge for Cancer Research Biobanks?
    Watson PH
    Clin Cancer Res; 2017 Feb; 23(4):894-898. PubMed ID: 27551001
    [No Abstract]   [Full Text] [Related]  

  • 16. Finding the Value in Biobanks: Enhancing the CTRNet Locator.
    Matzke LA; Tarling TE; Gali B; Dee S; LeBlanc J; Vercauteren S; Watson PH
    Biopreserv Biobank; 2022 Apr; 20(2):132-137. PubMed ID: 34252293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a 'Repository of Science': The importance of integrating biobanks within molecular pathology programmes.
    Lewis C; McQuaid S; Hamilton PW; Salto-Tellez M; McArt D; James JA
    Eur J Cancer; 2016 Nov; 67():191-199. PubMed ID: 27677055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Many Health Research Biobanks Are There?
    O'Donoghue S; Dee S; Byrne JA; Watson PH
    Biopreserv Biobank; 2022 Jun; 20(3):224-228. PubMed ID: 34582255
    [No Abstract]   [Full Text] [Related]  

  • 19. Research Perspective on Utilizing and Valuing Tumor Biobanks.
    Rush A; Matzke L; Cooper S; Gedye C; Byrne JA; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):219-229. PubMed ID: 30575428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.